{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:33:55Z","timestamp":1761129235645,"version":"3.30.0"},"reference-count":21,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3201\/eid2106.141329","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T11:48:49Z","timestamp":1430308129000},"page":"977-983","source":"Crossref","is-referenced-by-count":12,"title":["Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries"],"prefix":"10.3201","volume":"21","author":[{"given":"Ekaterina V.","family":"Kurbatova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Ershova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thelma","family":"Tupasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice Campos","family":"Caoili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martie","family":"Van Der Walt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Kvasnovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Yagui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Bayona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaira","family":"Leimane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Via","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HeeJin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsak","family":"Akksilp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris Y.","family":"Kazennyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigory V.","family":"Volchenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruwen","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kliiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Demikhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Peter","family":"Cegielski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2106.141329-201505141330-R1","unstructured":"World Health Organization. Global tuberculosis report 2013. Geneva: The Organization; 2013."},{"key":"key-10.3201\/eid2106.141329-201505141330-R2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1473-3099(13)70130-0","article-title":"Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data.","volume":"13","author":"Falzon","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2106.141329-201505141330-R3","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update. Geneva: The Organization; 2008."},{"key":"key-10.3201\/eid2106.141329-201505141330-R4","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 update. Geneva: The Organization; 2011."},{"key":"key-10.3201\/eid2106.141329-201505141330-R5","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2106.141329-201505141330-R6","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.","volume":"4","author":"Johnston","year":"2009","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2106.141329-201505141330-R7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.","volume":"9","author":"Orenstein","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2106.141329-201505141330-R8","unstructured":"RESIST-TB. DR-TB clinical trial progress report [cited 2014 Jul 11]. http:\/\/www.resisttb.org\/?page_id=1602"},{"key":"key-10.3201\/eid2106.141329-201505141330-R9","first-page":"1","article-title":"Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2106.141329-201505141330-R10","unstructured":"World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance. Geneva: The Organization; 2013."},{"key":"key-10.3201\/eid2106.141329-201505141330-R11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.","volume":"182","author":"Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid2106.141329-201505141330-R12","unstructured":"ISRCTN registry. The evaluation of a standardised treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (MDR-TB). ISRCTN78372190 [cited 2014 Jul 11]. http:\/\/www.isrctn.com\/ISRCTN78372190"},{"key":"key-10.3201\/eid2106.141329-201505141330-R13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.","volume":"380","author":"Dalton","year":"2012","journal-title":"Lancet"},{"key":"key-10.3201\/eid2106.141329-201505141330-R14","unstructured":"World Health Organization. The use of short regimens for treatment of multidrug-resistant tuberculosis [cited 2014 Jul 11]. http:\/\/www.who.int\/tb\/challenges\/mdr\/short_regimen_use\/en\/"},{"key":"key-10.3201\/eid2106.141329-201505141330-R15","first-page":"139","article-title":"A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.","volume":"12","author":"Katiyar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2106.141329-201505141330-R16","unstructured":"ClinicalTrials.gov. High-dose isoniazid among adult patients with different genetic variants of INH-resistant tuberculosis (TB) [cited 2014 Jul 11]. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01936831"},{"key":"key-10.3201\/eid2106.141329-201505141330-R17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2106.141329-201505141330-R18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1471-2334-11-240","article-title":"Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.","volume":"11","author":"Chiu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2106.141329-201505141330-R19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1471-2180-10-223","article-title":"Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.","volume":"10","author":"Jonmalung","year":"2010","journal-title":"BMC Microbiol"},{"key":"key-10.3201\/eid2106.141329-201505141330-R20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5588\/ijtld.10.0739","article-title":"Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.","volume":"16","author":"Kim","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2106.141329-201505141330-R21","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1128\/JCM.00973-08","article-title":"Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.","volume":"46","author":"Mphahlele","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/21\/6\/14-1329_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:21:17Z","timestamp":1732922477000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/6\/14-1329_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2106.141329","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}